PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics - Image 1

£142.37

Springer PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics

Name: PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics
Brand: Springer
Price: 166.44 GBP
Availability: InStock

Pharmacy - Dispensing

Price History & Forecast

Last 59 days • 59 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 59 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £166 (57 days, 96.6%)

Price range: £142 - £166

Price levels: 2 different prices over 59 days

Description

This book is a comprehensive coverage of the ubiquitin-proteasome system and its involvement in cancer progression, and the application of PROTACs in different types of cancer treatment. The book discusses a unique perspective and comprehensive knowledge of the potential of PROTACs to transform cancer therapies. It provides an overview of the history, mechanisms, chemistry, design considerations, and different technologies involved in PROTACs. Additionally, it explains the ubiquitin-proteasome system, its impact on various diseases, and the principles and mechanisms of UPS. The book also describes the chemistry and design aspects of PROTACs and their role in various types of cancers. Finally, it covers the pharmaceutics aspect of formulation design, global requirements, and toxicological aspects of PROTACs. This book is targeted at cancer researchers, medical oncologists, bioinformatics, computational biologists, pharmacologists, medicinal chemists, formulation scientists, regulatory authorities, and policy makers.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 9819750768
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 01 September 2024
Listed Since: 07 June 2024

Barcode

No barcode data available

Springer PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Modulation of Protein Stability in Cancer Therapy

Humana Targeted Protein Degradation: Methods and Protocols 2365

Targeted Protein Degradation: Methods and Protocols: 2365 (Methods in Molecular Biology, 2365)

Ubiquitin Family Modifiers and the Proteasome: Reviews and Protocols: 832 (Methods in Molecular Biology, 832)

Ubiquitin-Proteasome Protocols: 301 (Methods in Molecular Biology, 301)

Royal Society of Chemistry Protein Degradation Book Vol 74

Inducing Targeted Protein Degradation: From Chemical Biology to Drug Discovery and Clinical Applications

Small Molecules in Oncology: 201 (Recent Results in Cancer Research)

New Frontiers in Chemical Biology: Enabling Drug Discovery: Volume 5 (Drug Discovery Series)

Proteomics for Drug Discovery: Methods and Protocols: 1647 (Methods in Molecular Biology, 1647)

Humana Protein Kinase C in Cancer Signaling and Therapy Book

Poly(ADP-ribose) Polymerase: Methods and Protocols: 780 (Methods in Molecular Biology, 780)

Springer - The Cancer Degradome: Proteases and Cancer Biology

Springer HSF1 and Molecular Chaperones in Biology and Cancer

Springer Post-Translational Modifications in Health and Disease 13

Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)

PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development)

Modern Protein Chemistry: Practical Aspects

New Trends in the Molecular and Biological Basis for Clinical Oncology

The Proteasome in Neurodegeneration

Proteases and Cancer: Methods and Protocols: 539 (Methods in Molecular Biology, 539)

Springer Protein Targeting Compounds - Advances in Biology 917

Cell Surface GRP78, a New Paradigm in Signal Transduction Biology

Chemical Biology: Methods and Protocols: 1263 (Methods in Molecular Biology, 1263)